Updated Date: Thu, 04 Feb 2021 00:00:00 EST
Category: Uncategorized
Whenever there is widespread uncertainty about the balance between the benefits and harms of a therapeutic intervention—which clearly […]
One third (35%) of people who took a new drug for treating obesity lost more than one-fifth of […]
Merck canned its own COVID-19 vaccines. Now, it’s in talks to manufacture other companies’ shots esagonowsky Thu, 02/11/2021 […]
Novo Nordisk makes headway in bid to rule obesity market with stunning phase 3 semaglutide data arlene.weintraub Thu, […]
AstraZeneca teams with IDT Biologika to speed coronavirus vaccine output in EU fkansteiner Thu, 02/11/2021 – 09:37
AstraZeneca’s COVID-19 vaccine launch is the headline-grabber, but new drug launches drove 2020 growth esagonowsky Thu, 02/11/2021 – […]
Novartis’ Sandoz doubles down on antibiotics with $500M deal for GSK brands bbulik Thu, 02/11/2021 – 11:29
Researchers have developed a new antibiotic that can help in the fight against resistant bacteria, and they hope […]
